Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
India
· Delayed Price · Currency is INR 233.00
-2.02 (-0.86%)
Jun 13, 2025, 3:29 PM IST
Jagsonpal Pharmaceuticals Market Cap
Jagsonpal Pharmaceuticals has a market cap or net worth of 15.64 billion as of June 13, 2025. Its market cap has increased by 72.83% in one year.
Market Cap
15.64B
Enterprise Value
14.44B
Revenue
2.69B
Ranking
n/a
PE Ratio
28.59
Stock Price
233.00
Market Cap Chart
Since March 1, 2000, Jagsonpal Pharmaceuticals's market cap has decreased from 17.63B to 15.64B, a decrease of -11.32%. That is a compound annual growth rate of -0.47%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,048.64B |
| Divi's Laboratories | 1,785.28B |
| Cipla | 1,213.80B |
| Apollo Hospitals Enterprise | 1,005.99B |
| Mankind Pharma | 986.42B |
| Zydus Lifesciences | 984.90B |
| Aurobindo Pharma | 670.94B |
| Alkem Laboratories | 579.47B |